Delivery Order SPE2DB25D2204-SPE2DB25FTGTL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,096.88 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on August 14, 2025. The contract is classified as firm fixed price with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $6,518.07 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order executed under an existing contract vehicle and requires fulfillment within an...
- The Defense Logistics Agency (DLA) awarded a $2,807.37 delivery order to AmerisourceBergen Drug Corp for supply of Zepbound 7.5 mg/0.5 mL pen injectors, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child purchase order under a larger contract vehicle supporting federal pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on July 25, 2025, with a contract ceiling value of $46,927.70 and a completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The order represents a single transaction within...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injections with a ceiling value of $3,648.19. This firm fixed-price delivery order is set to be completed by July 30, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation and represents a routine pharmaceutical supply transaction under the...
- The Defense Logistics Agency awarded a $6,968.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on August 7, 2025. This non-set-aside contract represents a single delivery order fulfillment with an ultimate completion date of August 8, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office and serves as a critical federal medical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,525.28 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract supporting federal pharmaceutical procurement needs. The products will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a delivery order valued at $3,826.25 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,048.25 for Zepbound 10 mg/0.5 mL pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $5,247.35 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on July 26, 2025, with completion scheduled for July 28, 2025. This firm fixed-price delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, and does not utilize a set-aside designation. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTGTLDelivery Order
The Defense Logistics Agency awarded a $24,689.72 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The product delivery supports federal medical procurement needs, particularly for military and veteran healthcare systems under the DLA's pharmaceutical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contracting portfolio with DLA focused on delivering specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.7k | 7/18/25 |